Mexico: Climbing to the top of the Pyramid
Mexico, which has over a hundred million inhabitants, has become the world’s ninth biggest pharmaceutical market and the largest in Latin America, surpassing Brazil for the first time in its…
UDIMEB was started back in the 1970s as Proyecto Factor de Transferencia (transfer factor project) by Dr Sergio Estrada-Parra, the father of immunology in Mexico and winner of the National Science Award in 2012, who deepened research on transfer factors to develop an immunomodulatory drug which could be used locally. Today UDIMEB is a three-armed institution which comprises UDIBI, a national laboratory unit offering R&D bioprocess services to the private industry and the academia; USEIC, an institution providing free clinical services in the field of immunology and alternative treatments based on transfer factors to more than 20,000 patients; and FARMA FT, the company in charge of manufacturing the immunomodulatory drug Transferon®.
Contact Details:
UDIMEB
Escuela Nacional de Ciencias Biológicas (ENCB) IPN.
Prolongación de Carpio y Plan de Ayala S/N
Col. Casco de Santo Tomas, Del. Miguel Hidalgo
C.P 11340 MÉXICO DF
MEXICO
Tel: +52 (55) 57296000
Website: http://udibi.com.mx/
Mexico, which has over a hundred million inhabitants, has become the world’s ninth biggest pharmaceutical market and the largest in Latin America, surpassing Brazil for the first time in its…
Mexico, which has over a hundred million inhabitants, has become the world’s ninth biggest pharmaceutical market and the largest in Latin America, surpassing Brazil for the first time in its…
See our Cookie Privacy Policy Here
